Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 5

    Torrent Pharma says promoters havent pledged shares

    Torrent Pharma says promoters haven't pledged shares

    Medical Dialogues Bureau6 April 2020 11:45 AM IST
    New Delhi: Torrent Pharma has said that its promoters have not pledged any equity shares they hold in the company for any purpose, and a surveillance...
    Govt tightens export ban norms for anti-malarial drug hydroxychloroquine

    Govt tightens export ban norms for anti-malarial drug hydroxychloroquine

    Medical Dialogues Bureau6 April 2020 10:00 AM IST
    New Delhi: The government has tightened the export ban norms on anti-malarial drug hydroxychloroquine by including special economic zones (SEZs) under...
    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

    Medical Dialogues Bureau6 April 2020 9:15 AM IST
    The U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

    Medical Dialogues Bureau5 April 2020 2:41 PM IST
    Mumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol...
    CDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemic

    CDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemic

    Medical Dialogues Bureau5 April 2020 2:19 PM IST
    New Delhi: Through the recent circular Central Drugs Standard Control Organisation(CDSCO), Directorate General of Health Services has stated the...
    Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

    Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

    Medical Dialogues Bureau5 April 2020 2:15 PM IST
    New York: Pfizer Inc. has announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar...
    Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India

    Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India

    Medical Dialogues Bureau5 April 2020 2:07 PM IST
    Mumbai: Thermo Fisher Scientific Inc., the world leader in serving science, is accelerating its efforts with diagnostic testing and vaccine...
    DeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen Coronavirus

    DeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen Coronavirus

    Medical Dialogues Bureau5 April 2020 11:00 AM IST
    Pune: Recently there have been notable developments in health tech diagnostics due to Artificial Intelligence tools for analyzing medical scans like...
    Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA

    Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA

    Medical Dialogues Bureau4 April 2020 2:09 PM IST
    BCMA is a protein that is nearly universally expressed on cancer cells in multiple myeloma, making it an important potential target for the treatment...
    Lupin gets USFDA EIR for Aurangabad Facility

    Lupin gets USFDA EIR for Aurangabad Facility

    Medical Dialogues Bureau4 April 2020 1:38 PM IST
    Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
    HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

    HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

    Medical Dialogues Bureau4 April 2020 1:36 PM IST
    Horlicks has a volume share of close to 50 per cent in the HFD market
    AstraZeneca divestment of Movantik to RedHill Biopharma completed

    AstraZeneca divestment of Movantik to RedHill Biopharma completed

    Medical Dialogues Bureau4 April 2020 11:00 AM IST
    UK: AstraZeneca has completed the previously communicated agreement to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada,...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok